Integra Lifesciences Holdings (IART) Exchange Rate Effect (2009 - 2026)
Integra Lifesciences Holdings (IART) reported Exchange Rate Effect of -$1.5 million for Q1 2026, down 132.92% on a YoY basis from $4.5 million in Q1 2025, and down 192.55% sequentially from $1.6 million in Q4 2025.
Integra Lifesciences Holdings (IART) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings (IART) has 18 years of Exchange Rate Effect data on file, last reported at -$1.5 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 132.92% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2026 stood at $12.0 million (up 296.2% YoY), and the FY2025 full-year result was $18.0 million, up 378.73% from the prior year.
- Exchange Rate Effect declined to -$1.5 million in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $12.7 million in Q2 2025 to a low of -$10.7 million in Q3 2022.
- A 5-year average of $189882.4 and a median of -$801000.0 in 2025 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect sank 629.67% in 2024 and jumped 1226.93% in 2025, its largest moves.
- Tracing IART's Exchange Rate Effect over 5 years: stood at $11.9 million in 2022, then slumped by 32.5% to $8.0 million in 2023, then tumbled by 201.04% to -$8.1 million in 2024, then jumped by 119.83% to $1.6 million in 2025, then tumbled by 192.55% to -$1.5 million in 2026.
- Business Quant data shows IART's Exchange Rate Effect at -$1.5 million in Q1 2026, $1.6 million in Q4 2025, and -$801000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -23.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -19.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 33.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 8.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -2.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.66 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -37.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integra Lifesciences Holdings | 1.71 Bn | 1.45 Bn | 216.98 Mn | -1.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.49 Mn |
| Mar 31, 2026 | -1.49 Mn |
| Dec 31, 2025 | 1.61 Mn |
| Dec 31, 2025 | 1.61 Mn |
| Sep 30, 2025 | -801,000.00 |
| Sep 30, 2025 | -801,000.00 |
| Jun 30, 2025 | 12.68 Mn |
| Jun 30, 2025 | 12.68 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Dec 31, 2024 | -8.12 Mn |
| Dec 31, 2024 | -8.12 Mn |
| Sep 30, 2024 | 7.75 Mn |
| Sep 30, 2024 | 7.75 Mn |
| Jun 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -1.13 Mn |
| Mar 31, 2024 | -4.96 Mn |
| Mar 31, 2024 | -4.96 Mn |
| Dec 31, 2023 | 8.04 Mn |
| Dec 31, 2023 | 8.04 Mn |